-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

637. Myelodysplastic Syndromes – Clinical Studies: Poster II

Myelodysplastic Syndromes – Clinical Studies Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 6, 2015: 6:00 PM-8:00 PM
Hall A, Level 2 (Orange County Convention Center)

Guillermo Garcia-Manero, MD1, Mikkael A. Sekeres, MD, MS2, Miklos Egyed3, Giuliana Alimena, MD4, Carlos Graux5*, Jamie D. Cavenagh, MD6, Huda Salman7*, Arpad Illes, MD, PhD8*, Pierre Fenaux, MD, PhD9, Daniel J. DeAngelo10, Reinhard Stauder, MD, MSc11*, Karen Yee, MD12, Nancy Y Zhu, MD FRCPC13*, Je-Hwan Lee, MD, PhD14, David Valcarcel, MD, PhD15, Alan MacWhannell16*, Zita Borbenyi, MD, PhD17, Antje Wegener18*, Lucien Gazi19*, Suddhasatta Acharyya, PhD20*, Florence Binlich18* and Oliver G. Ottmann, MD21*

1Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, Houston, TX
2Leukemia Program, Cleveland Clinic, Cleveland, OH
3Kaposi Mór Teaching Hospital, Kaposvár, Hungary
4Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy
5Mont-Godinne University Hospital, Yvoir, Belgium
6Barts Health NHS Trust, London, United Kingdom
7Georgia Regents University, Augusta, GA
8Department of Hematology, University of Debrecen Medical and Health Science Center, Debrecen, Hungary
9Service d'Hématologie Séniors, Hôpital Saint-Louis, Université Paris 7, Paris, France
10Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
11Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University, Innsbruck, Austria
12Princess Margaret Hospital, Toronto, Canada
13Division of Hematology, University of Alberta, Edmonton, AB, Canada
14Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
15Department of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain
16The Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, United Kingdom
172nd Department of Internal Medicine-Hematological Unit, University of Szeged Faculty of Medicine, Szeged, Hungary
18Novartis Pharma SAS, Rueil-Malmaison, France
19Novartis Pharma AG, Basel, Switzerland
20Novartis Pharmaceuticals Corporation, East Hanover, NJ
21Department of Haematology, Cardiff University, Cardiff, United Kingdom

Uwe Platzbecker, MD1, Ulrich Germing, MD2*, Aristoteles Giagounidis, MD, PhD3, Katharina Götze, MD4*, Philipp Kiewe, MD5*, Karin Tina Mayer, MD6*, Oliver Ottmann, MD7, Markus Radsak, MD8*, Thomas Wolff, MD9, Detlef Haase, MD10*, Monty Hankin11*, Dawn Wilson11*, Xiaosha Zhang11*, Abderrahmane Laadem, MD12, Matthew L. Sherman, MD11 and Kenneth M. Attie, MD11

1Carl Gustav Carus an der Technischen Universität, Universitätsklinikum, Dresden, Germany
2Universitätsklinikum Düsseldorf, Düsseldorf, Germany
3Marien Hospital Düsseldorf, Düsseldorf, Germany
4Technical University of Munich, Munich, Germany
5Onkologischer Schwerpunkt am Oskar-Helene-Heim, Berlin, Germany
6Department of Internal Medicine III, University Hospital Bonn, Bonn, Germany
7Universitätsklinikum Frankfurt, Goethe Universitaet, Frankfurt/Main, Germany
8University Medical Center - Johannes Gutenberg-Universität, Mainz, Germany
9OncoResearch Lerchenfeld UG, Hamburg, Germany
10Department of Hematology and Medical Oncology, Universitätsmedizin Göttingen, Göttingen, Germany
11Acceleron Pharma, Cambridge, MA
12Celgene Corporation, Summit, NJ

Hagop Kantarjian, MD1, Ghulam J. Mufti, MD, PhD2, Pierre Fenaux, MD, PhD3, Mikkael A. Sekeres, MD, MS4, Jeffrey Szer, MB BS FRACP5, Uwe Platzbecker, MD6, Andrea Kuendgen, MD7*, Gianluca Gaidano8, Wieslaw Wiktor-Jedrzejczak, MD, PhD9*, Janet Franklin, MD, MPH10 and Aristoteles Giagounidis, MD11

1Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
2Haematological Medicine, King's College London, London, United Kingdom
3Service d'Hématologie Clinique, Hopital Avicenne Université Paris XIII, Bobigny, France
4Leukemia Program, Cleveland Clinic, Cleveland, OH
5Clinical Haematology, Royal Melbourne Hospital, Melbourne, Australia
6Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus, Dresden, Germany
7Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany
8Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
9Department of Hematology, Oncology and Internal Diseases, Medical University of Warsaw, Warsaw, Poland
10Amgen Inc., Thousand Oaks, CA
11Klinik für Onkologie, Hämatologie und Palliativmedizin, Marienhospital Düsseldorf, Düsseldorf, Germany

Mrinal M Patnaik, MBBS1, Terra L. Lasho, PhD1*, Pooja Vijayvargiya1*, Christy Finke, BS2*, Curtis A. Hanson, MD3, Rhett P. Ketterling, MD4*, Naseema Gangat, MBBS1 and Ayalew Tefferi, MD5

1Division of Hematology, Mayo Clinic, Rochester, MN
2Mayo Clinic, rochester, MN
3Division of Hematopathology, Mayo Clinic, Rochester, MN
4Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
5Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN

Louise De Swart, MD1*, Chloé Reiniers2*, Tim Bagguley3*, David Bowen, MD, PhD4, Jaroslav Cermak, MD, PhD,5, Eva Hellström-Lindberg, MD, PhD6, Aurelia Tatic, MD7*, Argiris Symeonidis, MD, PhD8, Gerwin Huls, MD, PhD9*, Panagiotis Panagiotidis10*, Hege Garelius, MD11*, Dominic Culligan12, Marta Krejci13*, Corine van Marrewijk1*, Jackie Droste, PhD1*, Alexandra Smith3*, Dorine W. Swinkels, MD, PhD14 and Theo de Witte, MD, PhD15

1Hematology, Radboudumc, Nijmegen, Netherlands
2Radboudumc, Nijmegen, Netherlands
3Epidemiology and Cancer Statistics Group, University of York, York, United Kingdom
4St. James's Institute of Oncology, Leeds Teaching Hospitals, Leeds, United Kingdom
5Department of Clinical Hematology, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
6Division of Hematology, Department of Medicine, Karolinska Institutet at Karolinska University Hospital Stockholm, Stockholm, Sweden
7Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania
8Hematology, University of Patras Medical School, Patras, Greece
9Department of Hematology, Radboud university medical center, Nijmegen, Netherlands
10First Department of Propaedeutic Medicine, University of Athens, Athens, Greece
11Department of Medicine, Sect. of Hematology and Coagulation, Sahlgrenska University Hospital, Göteborg, Sweden
12NHS Grampian, Aberdeen Royal Infirmary, Aberdeen, United Kingdom
13Dep. of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic
14Dep. of Laboratory Medicine, Radboudumc, Nijmegen, Netherlands
15Nijmegen Center for Molecular Life Sciences, Dep. of Tumor Immunology, Radboud University of Nijmegen Medical Centre, Nijmegen, Netherlands

Xavier Calvo, MD1*, Leonor Arenillas, MD1*, Mar Tormo, MD, PhD2, David Valcárcel, MD, PhD3, Elisa Luño, MD, PhD4*, Esther Alonso, MD5*, María Díez-Campelo, MD, PhD6*, Fernando Ramos, MD, PhD, MPH7*, Carmen Pedro, MD, PhD8*, Beatriz Arrizabalaga, MD9*, Alicia Bailén, MD10*, José María Raya, MD11*, María Teresa Ardanaz, MD12*, Guillermo Sanz, MD, PhD13 and Lourdes Florensa, MD, PhD1*

1Hematological Cytology Laboratory, Hospital del Mar, GRENTHE, IMIM (Hospital del Mar Research Institute), Barcelona, Spain
2Hospital Clínico Universitario de Valencia, Valencia, Spain
3Hospital Vall d'Hebrón, Barcelona, Spain
4Hematology, Hospital Universitario Central Asturias, Oviedo, Spain
5Hematology, Department of Pathology. Hospital de Bellvitge., Barcelona., Spain
6Hematology, Hospital Universitario de Salamanca, Salamanca, Spain
7Hospital Universitario de León, León, Spain
8Hospital del Mar, Barcelona, Spain
9Hospital Universitario Cruces, Spanish MDS Cooperative Group, Bilbao, Spain
10Hospital Universitario Carlos Haya, Málaga, Spain
11Hospital Universitario de Canarias, Tenerife, Spain
12Hospital de Txagorritxu, Vitoria, Spain
13Hospital Universitario La Fe, Spanish MDS Cooperative Group, Valencia, Spain

Aaron T. Gerds, MD, MS1, Alan F. List, MD2, Aristoteles Giagounidis, MD, PhD3, Eva Hellström-Lindberg, MD, PhD4*, Jack Shiansong Li, PhD5*, Arlene S. Swern, PhD5*, Mary M. Sugrue, MD, PhD5*, Pierre Fenaux, MD, PhD6 and Mikkael A. Sekeres, MD, MS7

1Leukemia Program, Cleveland Clinic, Cleveland, OH
2Division of Clinical Science, Moffitt Cancer Center and Research Institute, Tampa, FL
3Marien Hospital Düsseldorf, Düsseldorf, Germany
4Karolinska University Hospital, Stockholm, Sweden
5Celgene Corporation, Summit, NJ
6Service d'Hématologie Séniors, Hôpital Saint-Louis, Université Paris 7, Paris, France
7Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH

Takahiro Suzuki, MD, PhD1, Yasunori Ueda, MD, PhD2, Michinori Ogura, MD, PhD3,4, Toshiki Uchida, MD, PhD4*, Keiya Ozawa, MD, PhD5, Shigesaburo Miyakoshi, MD, PhD6*, Tomoki Naoe, MD, Ph.D.7, Makoto Murata, MD, PhD7, Masahiro Kizaki, MD, PhD8, Naokuni Uike, MD9*, Yasunobu Abe, MD, PhD9*, Michihiro Hidaka, MD, PhD10*, Shuzo Tagashira11*, Satoru Tsuchiya11*, Kazuma Ohyashiki, MD, PhD12 and Yasushi Miyazaki, MD, Ph.D.13

1Division of Hematology, Department of Medicine, Jichi Medical University, Shimotsuke, Japan
2Department of Haematology/Oncology, Kurashiki Central Hospital, Kurashiki City, Okayama, Japan
3Department of Hematology, Tokai Central Hospital, Kakamigahara, Japan
4Department of Hematology and Oncology, Nagoya Daini Red Cross Hospital, Nagoya, Japan
5Division of Hematology, Departiment of Medicine, Jichi Medical University, Shimotsuke, Japan
6Department of Hematology, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Tokyo, Japan
7Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
8Department of Hematology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan
9Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
10Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan
11Sumitomo Dainippon Pharma Co.,Ltd., Tokyo, Japan
12Department of Hematology, Tokyo Medical University, Tokyo, Japan
13Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan

Lionel Ades, MD, PhD1, Agnes Guerci-Bresler, MD2*, Pascale Cony-Makhoul, MD3*, Laurence Legros, MD4*, Marie Sebert, MD5*, Thorsten Braun, MD, PhD6*, Jacques Delaunay, MD7*, Benedicte Samey8*, Kristell Desseaux9*, Sylvie Chevret10* and Pierre Fenaux, MD, PhD11,12

1Service d’Hématologie Séniors, St Louis hospital, University Paris 7, Paris, France
2Hematology department, Hôpital d'Adultes du Brabois, CHU Nancy, Nancy, France
3CHANGE, PRINGY CEDEX, France
4Hematology department, Hopital Archet 1, CHU Nice, Nice, France
5Hopital Saint Louis, Paris, France
6Hematologie Clinique, CHU Avicenne, Bobigny, France
7Department of Hematology, Nantes University Hospital, Nantes, France
8Groupe Francophone des myélodysplasies, Paris, France
9DBIM, Paris, France
10Biostatistics department, Hôpital Saint-Louis, Paris, France
11Service d'Hématologie Séniors, Hôpital Saint-Louis, Université Paris 7, Paris, France
12Groupe Francais des myélodysplasies (GFM), Paris, France

Mikkael A. Sekeres, MD, MS1, Arlene S. Swern, PhD2*, Alan F. List, MD3, Pierre Fenaux, MD, PhD4 and Mary M. Sugrue, MD, PhD2*

1Leukemia Program, Cleveland Clinic, Cleveland, OH
2Celgene Corporation, Summit, NJ
3Department of Hematologic Malignancies, Moffitt Cancer Center and Research Institute, Tampa, FL
4Service d'Hématologie Séniors, Hôpital Saint-Louis, Université Paris 7, Paris, France

Carlo Finelli, MD1*, Cristina Clissa, M.D.2*, Matilde Follo, PhD3*, Marta Stanzani, M.D.1*, Sarah Parisi, M.D.1*, Sara Mongiorgi, PhD3*, Paolo Avanzini, MD4*, Costanza Bosi, M.D.5*, Barbara Castagnari, M.D.6*, Anna Candoni, MD7*, Monica Crugnola, MD8*, Maria Benedetta Giannini, M.D.9*, Marco Gobbi, MD10*, Giovanna Leonardi11*, Gian Matteo Rigolin12*, Domenico Russo13, Patrizia Tosi14*, Giuseppe Visani, M.D.15*, Lucio Cocco, M.D., PhD3* and Michele Cavo16*

1Hematology, S.Orsola-Malpighi University Hospital, Bologna, Italy
2Hematology and Stem Cell Transplant Center, AORMN Hospital, Pesaro, Italy
3Biomedical Sciences-Human Anatomy, University of Bologna, Bologna, Italy
4Hematology, S.Maria Nuova Hospital, Reggio Emilia, Italy
5Hematology, Guglielmo da Saliceto Hospital, Piacenza, Italy
6Hematology, S. Maria delle Croci Hospital, Ravenna, Italy
7Hematology, Santa Maria della Misericordia University Hospital, Udine, Italy
8Clinical and Experimental Medicine, University of Parma, Parma, Italy
9Oncology, I.R.S.T., Meldola (FC), Italy
10Chair of Hematology, Department of Internal Medicine (DiMI), IRCCS AOU San Martino-IST, University of Genoa, Genoa, Italy
11Hematology, University of Modena, MODENA, Italy
12Hematology Section, Azienda Ospedaliero-Universitaria S. Anna, University of Ferrara, Ferrara, Italy
13Chair of Hematology, University of Brescia, Brescia, Italy
14Oncology and Hematology, Infermi Hospital, Rimini, Italy
15Hematology, S.Salvatore Hospital, Pesaro, Italy
16Institute of Hematology, Bologna, Italy

Matthieu Duchmann1*, Thorsten Braun, MD, PhD2*, Olivier Kosmider, MD, PhD3*, Aline Renneville4*, Uwe Platzbecker, MD5, Lionel Ades, MD, PhD6, Marie Sebert, MD7*, François Dreyfus, MD8*, Sophie Park, MD, PhD9, Norbert Vey10, Odile Beyne Rauzy, MD, PhD11*, Stéphane De Botton, MD, PhD12*, Jean-Baptiste Micol, MD13*, Romain Guieze, MD14*, Jean-Noel M. Bastie, MD, PhD15, Claude Preudhomme, MD, PhD16, Michaela Fontenay, MD, PhD9*, Éric Solary, MD, PhD17*, Pierre Fenaux, MD, PhD18 and Raphaël Itzykson, MD, PhD19

1Université Paris 7 Diderot, Paris, France
2Clinical Hematology, CHU Avicenne, Bobigny, France
3APHP Laboratoire d'Hématologie, Hôpital Cochin, Paris, France
4Hematology Laboratory, CHRU, Lille, France
5Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus, Dresden, Germany
6Service d’Hématologie Séniors, St Louis hospital, University Paris 7, Paris, France
7Hospital Saint Louis, University Paris 7, Paris, France
8Cochin hospital, University Paris 5, Paris, France
9Cochin Hospital, University Paris 5, Paris, France
10Hematology, Institut Paoli-Calmettes, Marseille, France
11IUCT Oncopole, CHU Toulouse, Toulouse, France
12Clinical Hematology, Gustave Roussy, Villejuif, France
13Gustave Roussy Cancer Center, Villejuif, France
14Clinical Hematology, CHU Clermont-Ferrand, Clermont Ferrand, France
15CHU Dijon Bocage, Dijon, France
16Hôpital Claude Huriez, Lille, France
17Gustave Roussy, Villejuif, France
18University Paris 7 Diderot, Hôpital Saint-Louis, Paris, France
19Hematology Department, Saint-Louis Hospital, University Paris 7, Paris, France

Pragya Srivastava, PhD1*, Junko Matsuzaki, PhD2*, Benjamin E. Paluch3*, Zachary Brumberger1*, Stephanie Kaufman2*, Adam R. Karpf, PhD4*, Kunle Odunsi, MD/PhD2,5*, Austin Miller, PhD6*, Justin Kocent1*, Eunice S. Wang, MD1, Michael J. Nemeth, PhD1,5 and Elizabeth A. Griffiths, MD1,3,5

1Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY
2Center for Immunotherapy, Roswell Park Cancer Institute, Buffalo, NY
3Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY
4Eppley Institute, Fred & Pamela Buffett Cancer Center, Omaha, NE
5Department of Immunology, Roswell Park Cancer Institute, Buffalo, NY
6Department of Biostatistics, Roswell Park Cancer Institute, Buffalo, NY

Bing Li, MD1*, Jinqin Liu2*, Shiqiang Qu, MD1*, Robert Peter Gale, MD, PhD, DSc3, Ruixian Xing1*, Tiejun Qin1*, Yue Zhang, MD2*, Zefeng Xu, MD2, Liwei Fang1*, Hongli Zhang, MD1*, Lijuan Pan1*, Naibo Hu1*, Gang Huang, PhD4 and Zhijian Xiao, MD2*

1MDS and MPN Centre, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
2State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
3Imperial College, London, United Kingdom
4Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Naseema Gangat, MBBS1, Mrinal M Patnaik, MBBS1, Kebede H. Begna, MD2, Aref Al-Kali, MD1, Mark R Litzow, MD1, Curtis A. Hanson, MD3, Rhett P. Ketterling, MD4*, Animesh Pardanani, MBBS, PhD5 and Ayalew Tefferi, MD2

1Division of Hematology, Mayo Clinic, Rochester, MN
2Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
3Division of Hematopathology, Mayo Clinic, Rochester, MN
4Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
5Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN

Gege Feng, MD1*, Wen Cui2*, Wenyu Cai2*, Tiejun Qin1*, Yue Zhang, MD2*, Zefeng Xu, MD2, Liwei Fang1*, Hongli Zhang, MD1*, Lijuan Pan1*, Naibo Hu1*, Bing Li, MD1* and Zhijian Xiao, MD2*

1MDS and MPN Centre, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
2State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Guillermo Montalban-Bravo, MD1*, Guillermo Garcia-Manero, MD2, Nicholas J. Short, MD3, Koji Sasaki, MD4, Mikkael A. Sekeres, MD, MS5, Rami S. Komrokji, MD6, David P. Steensma, MD7, Amy E. DeZern, MD, MHS8, Gail J. Roboz, MD9, Tapan Kadia, MD10, Gautam Borthakur, MD3, Courtney DiNardo, MD3, Darla Miller3*, Zeev Estrov, MD11, Naveen Pemmaraju, MD3, Naval Daver, MD12, Marina Konopleva, MD, PhD3, Jorge E. Cortes, MD3, Hagop M. Kantarjian, MD3 and Elias Jabbour3

1Department of Leukemia, M D Anderson Cancer Center, Houston, TX
2Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, Houston, TX
3Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
5Leukemia Program, Cleveland Clinic, Cleveland, OH
6Malignant Hematology Department, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL
7Dana-Farber Cancer Institute, Boston, MA
8Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
9Division of Hematology and Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY
10Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
11Department of Leukemia, The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, TX
12Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, Houston, TX

Su Wai Maung, MBBS, MRCP(UK)1,2*, Niamh Strahan, M.Sc1*, Philomena O'Byrne, M.Sc3,4*, Sarah O'Dowd, M.Sc5*, John O'Loughlin5*, Ronan Desmond, MD, FRCPath1, Johnny McHugh, FRCPath1*, Michael Jeffers, FRCPath5* and Helen Enright, MD, FRCPI, FRCPath1,2*

1Department of Haematology, Tallaght Hospital, Dublin, Ireland
2Department of Haematology, Trinity College Medical School, University of Dublin, Dublin, Ireland
3Department of Pharmacy, Tallaght Hospital, Dublin, Ireland
4Trinity College, University of Dublin, Dublin, Ireland
5Department of Cellular Pathology, Tallaght Hospital, Dublin, Ireland

Julie Schanz, MD, PhD1*, Heinz Tüchler2*, Francesc Sole, PhD3, Guillermo Sanz, MD, PhD4, Guillermo Garcia-Manero, MD5, Michelle M. Le Beau6, John M. Bennett, MD7, Marilyn L. Slovak, PhD8, Pierre Fenaux, MD, PhD9, Luca Malcovati, MD10*, Mario Cazzola, MD10, Peter Valent, MD11, Kazuma Ohyashiki, MD, PhD12, Alessandro Levis13, Mikkael A. Sekeres, MD, MS14, Sudhir Tauro, PhD15*, Silvia Magalhaes16*, A. A van de Loosdrecht17, Jaroslav Cermak, MD, Ph.D.18, Michael Luebbert, MD19*, Reinhard Stauder, MD, MSc20*, Eva Hellstrom-Lindberg, MD, PhD21, Tatjana Gindina, MD22*, Ulrich Germing, MD23*, Peter Greenberg, MD24 and Detlef Haase, MD25*

1Hematology and Medical Oncology, Goettingen, Germany
2Ludwig Boltzmann Institute for Leukemia Resaerch, Vienna, Austria
3MDS Research Group, Institut de Recerca Contra la Leucèmia Josep Carreras, ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain
4Hematology, Hospital Universitario La Fe, Valencia, Spain
5Department of Leukemia, MD Anderson Cancer Center, Houston, TX
6University of Chicago, Chicago, IL
7University of Rochester, Rochester, NY
8Signature Genomic Laboratories, Spokane, WA
9Service d'Hématologie Séniors, Hôpital Saint-Louis, Université Paris 7, Paris, France
10Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Pavia, Italy
11Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
12Department of Hematology, Tokyo Medical University, Tokyo, Japan
13Oncology and Hematology, Ospedale Civile, Alessandria, Italy
14Leukemia Program, Cleveland Clinic, Cleveland, OH
15Division of Cancer Research, Dundee School of Medicine, Dundee, United Kingdom
16Federal University of Ceara, Fortaleza, Brazil
17Department of Hematology, VU University Medical Center, Amsterdam, Netherlands
18Department of Clinical Hematology, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
19Department of Hematology, Oncology and Stem Cell Transplantation, University of Freiburg Medical Center, Freiburg, Germany
20Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University, Innsbruck, Austria
21Dept. of Med., Div. of Hem., Karolinska Institutet, Stockholm, Sweden
22R.M. Gorbacheva Memorial Institute of Children Hematology and Transplantation, I.P. Pavlov State Medical University, Saint Petersburg, Russia
23Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany
24Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA
25Department of Hematology and Medical Oncology, Georg-August-University Göttingen, Göttingen, Germany

Antonio Almeida, MD, PhD1*, Valeria Santini, MD2, Stefanie Gröpper, MD3*, Anna Jonasova, MD4*, Norbert Vey5, Aristoteles Giagounidis, MD, PhD3, Eva Hellström-Lindberg, MD, PhD6*, Ghulam J. Mufti, MD, PhD7, Guillermo Sanz, MD, PhD8, Barry Skikne, MD9, Albert Hoenekopp, MD10*, Francis Séguy10*, Jianhua Zhong, PhD9* and Pierre Fenaux, MD, PhD11

1Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal
2AOU Careggi, University of Florence, Florence, Italy
3Marien Hospital Düsseldorf, Düsseldorf, Germany
41st Department of Medicine, Charles University General Hospital, Prague, Czech Republic
5Institut Paoli-Calmettes Centre Régional de Lutte Contre le Cancer, Marseille, France
6Karolinska University Hospital, Stockholm, Sweden
7King's College Hospital, London, United Kingdom
8Hospital Universitario y Politécnico La Fe, Valencia, Spain
9Celgene Corporation, Summit, NJ
10Celgene International, Boudry, Switzerland
11Service d’Hématologie Séniors, Hôpital Saint-Louis, Université Paris 7, Paris, France

Louis Drevon1*, Alice Marceau2*, Virginie Eclache3*, S. Dominique Raynaud, MD4, Valentine Richez5*, Inès Berkaoui5*, Odile Maarek6*, Wendy Cuccuini6*, Daniel Lusina7*, Celine Berthon8*, Sophie Dimicoli-Salazar9*, Audrey Bidet10*, Jean-Philippe Vial10*, Sophie Park, MD, PhD11, Aspasia Stamatoullas, MD12*, Christina Vieira Dos Santos13*, Thorsten Braun, MD, PhD14*, Rosa Sapena15*, Aline Renneville16*, Lionel Ades, MD, PhD1 and Pierre Fenaux, MD, PhD1

1Clinical Hematology, CHU Saint-Louis, Paris, France
2Hematology Laboratory, CHRU Lille, Lille, France
3Hematology Laboratory, CHU Avicenne, Bobigny, France
4Laboratoire d'Oncohematolgie, Hopital Pasteur, Nice, France
5Hematology Laboratory, Hopital Pasteur, Nice, France
6Hematology Laboratory, CHU Saint-Louis, Paris, France
7Hematology Laboratory, CHU Avicenne, Paris, France
8Clinical Hematology, CHRU Lille, Lille, France
9Clinical Hematology, CHU Bordeaux, Bordeaux, France
10Hematology Laboratory, CHU Bordeaux, Bordeaux, France
11CHU de Grenoble, Clinique Universitaire d’Hématologie, Université Joseph Fourier, Grenoble Cedex 9, France
12Clinical Hematology, CENTRE HENRI BECQUEREL, Rouen, France
13Clinical Hematology, CHU Grenoble, Grenoble, France
14Clinical Hematology, CHU Avicenne, Bobigny, France
15Clinical Hematology, CHU Cochin, Paris, France
16Hematology Laboratory, CHRU, Lille, France

Naseema Gangat, MBBS1, Terra L. Lasho, PhD1*, Mrinal M Patnaik, MBBS1, Christy Finke, BS2*, Mark R Litzow, MD1, Curtis A. Hanson, MD3, Rhett P. Ketterling, MD4*, Animesh Pardanani, MBBS, PhD5 and Ayalew Tefferi, MD6

1Division of Hematology, Mayo Clinic, Rochester, MN
2Hematology, Mayo Clinic, Rochester, MN
3Division of Hematopathology, Mayo Clinic, Rochester, MN
4Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
5Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
6Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN

Laura Palomo, MSc1*, Blanca Xicoy, MD, PhD2*, Montse Arnan, MD3*, Marta Cabezon2*, Rosa Coll, MD4*, Vera Ademà, MSc1*, Francisco Fuster, MSc1*, Javier Grau, MD5*, María José Jiménez2*, Helena Pomares, MD6*, Sílvia Marcé, PhD2*, Maria Pilar Armengol, PhD7*, Mar Mallo, PhD1*, Fuensanta Millá, MD, PhD2*, Evarist Feliu, MD, PhD2*, Francesc Sole, PhD1 and Lurdes Zamora, PhD2*

1MDS Research Group, Institut de Recerca Contra la Leucèmia Josep Carreras, ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain
2Hematology Service, ICO-Hospital Germans Trias i Pujol, Institut de Recerca Contra la Leucèmia Josep Carreras, Universitat Autònoma de Barcelona, Badalona, Spain
3Hematology Service, ICO-Hospital Duran i Reynals, Barcelona, Spain
4Hospital Universitario de Girona Dr. Josep Trueta (ICO Girona), Girona, Spain
5Hematology Service, Institut Català d'Oncologia. Hospital Germans Trias i Pujol, Institut de Recerca Contra la Leucèmia Josep Carreras, Universitat Autònoma de Barcelona, Badalona, Spain
6Hospital Durán i Reynals, Barcelona, Spain
7Genomic and Microscopy facilities, Institut Investigació Ciències de la Salut Germans Trias i Pujol, Badalona, Spain

Marie Sebert, MD1,2*, Aspasia Stamatoullas, MD3*, Thorsten Braun, MD, PhD4*, Jacques Delaunay, MD5*, Benoît de Renzis6*, Ramzi Jeddi, MD7*, Balkis Meddeb8*, Mathilde Hunault Berger9*, Benedicte Samey1*, Fatiha Chermat1*, Sylvie Chevret10*, Cendrine Chaffaut11*, Pierre Fenaux, MD, PhD1,2 and Lionel Ades, MD, PhD1,12

1GFM, Hôpital Saint Louis, Paris, France
2Service d’Hématologie Séniors, Hôpital St Louis, Université Paris 7, Paris, France
3Clinical Hematology, CENTRE HENRI BECQUEREL, Rouen, France
4Hematologie Clinique, CHU Avicenne, Bobigny, France
5Department of Hematology, Nantes University Hospital, Nantes, France
6CHU Clermond Ferrand, Clermont Ferrand, France
7Aziza Othmana University Hospital, Tunis, Tunisia
8Aziza Othmana University Hospital, TUNIS, Tunisia
9CHU Angers, Angers, France
10Statistics St-Louis Hospital, Paris 7, Paris, France
11Departement de biostatistiques, hôpital Saitn-Louis, Paris, France
12Service d’Hématologie Séniors, St Louis hospital, University Paris 7, Paris, France

Jenny N Poynter, PhD1*, Michaela Richardson1*, Erica Langer1*, Anthony Hooten1*, Michelle A. Roesler, BS1*, Betsy A. Hirsch, PhD1*, Phuong L. Nguyen, MD2, Adina Cioc, MD3*, Erica Warlick, MD1 and Julie A Ross, PhD1*

1University of Minnesota, Minneapolis, MN
2Hematopathology, Mayo Clinic, Rochester, MN
3Hematopathology, VA Medical Center, Minneapolis, MN

Camille Bigenwald1*, Stephanie Harel2*, Florian Chevillon3*, Damien Roos-Weil4*, Olivier A. Bernard, PhD5*, Sandy Amorim, MD6*, Pauline Brice, MD7, Ades Lionel2*, Anne Marie Nloga2*, Marie Sébert, MD8*, Thorsten Braun, MD, PhD9*, Virginie Eclache10*, Catherine Thieblemont, MD PhD11 and Pierre Fenaux, MD, PhD12

1Onco-Hematology Department, Hôpital saint Louis/ Paris 7 University, Paris, France
2Hôpital saint Louis/ Paris 7 University, Paris, France
3Hôpital Avicenne / Paris 13 University, paris, France
4INSERM U1170, Institut Gustave Roussy, Villejuif, France
5Institut Gustave-Roussy, INSERM U985, Villejuif, France
6Hospital Saint-Louis, Paris, France
7Hematology-Oncology, Hospital Saint Louis, Paris, France
8Hospital St Louis, University Paris 7, Paris, France
9Clinical Hematology, CHU Avicenne, Bobigny, France
10Hematology Laboratory, CHU Avicenne, Bobigny, France
11Hemato-Oncology, Hopital Saint-Louis, APHP - INSERM U 728 - Institut Universitaire d'Hematologie, Paris, France
12University Paris 7 Diderot, Hôpital Saint-Louis, Paris, France

Wei Shen, PhD1*, Philippe Szankasi, PhD2, Maria Sederberg, MS2*, Jonathan Schumacher, MS2*, Kimberly Frizzell, PhD1*, Elaine P Gee, PhD3*, Jay L Patel, MD2,4*, Sarah T. South, PhD4,5*, Xinjie Xu, PhD2,4* and Todd W Kelley, MD2,4

1Genomics, ARUP Laboratories, Salt Lake City, UT
2ARUP Institute for Clinical and Experimental Pathology®, Salt Lake City, UT
3Clinical Laboratory Informatics and Integration, ARUP Laboratories, Salt Lake City, UT
4Department of Pathology, University of Utah, Salt Lake City, UT
5ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT

Aziz Nazha, MD1, Rami S. Komrokji, MD2, Guillermo Garcia-Manero, MD3, John Barnard, PhD4*, Katrina Zell, MA, MS4*, Cassie Zimmerman, MPH4*, Najla H. Al Ali, BDS, MSc5*, Gail J Roboz, MD6, David P. Steensma, MD7, Amy E. DeZern, MD, MHS8, Eric Padron, MD5, Elias J. Jabbour, MD3, Molly Dara Greenberg, BS9*, Alan F. List, MD10, Hagop M. Kantarjian, MD3, Jaroslaw P. Maciejewski, MD, PhD11 and Mikkael A. Sekeres, MD, MS4

1Leukemia Program, Department of Hematology and Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH
2H. Lee Moffitt Cancer Center, Tampa, FL
3Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
4Leukemia Program, Cleveland Clinic, Cleveland, OH
5Malignant Hematology Department, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL
6Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medical College, New York, NY
7Dana-Farber Cancer Institute, Boston, MA
8Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
9Division of Hematology and Oncology, New York Presbyterian Hospital-Weill Cornell Medical College, New York, NY
10Department of Hematologic Malignancies, Moffitt Cancer Center and Research Institute, Tampa, FL
11Experimental Hematology and Hematopoiesis Section, Taussig Cancer Center, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Amy E. DeZern, MD1, Amer M. Zeidan, MBBS, MHS2, John Barnard, PhD3*, Wesley Hand4*, Najla Al Ali5*, Francis Brown6*, Cassie Zimmerman, MPH3*, Gail J Roboz, MD7, Rami S. Komrokji, MD8, Guillermo Garcia-Manero, MD9, David P. Steensma, MD6 and Mikkael A. Sekeres, MD, MS10

1Cancer Research Building 1, Room 3M87, Baltimore, MD
2Yale School of Medicine, New Haven, CT
3Leukemia Program, Cleveland Clinic, Cleveland, OH
4Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
5H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
6Dana-Farber Cancer Institute, Boston, MA
7Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medical College, New York, NY
8Malignant Hematology Department, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL
9Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
10Leukemia Program, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

Juan Carlos Caballero, MD1,2*, Mercedes Sánchez-Barba3*, Mónica Del Rey4*, Kamila Janusz4*, Eva Lumbreras4*, María Abáigar4*, Robledo Cristina4*, Andrés Jerez5*, Esperanza Such, PhD6,7*, Guillermo Sanz, MD, PhD7,8, Cristina Calderon, MD9*, David Valcarcel, MD, PhD10, Jesus Maria Hernandez-Rivas, PhD1,4*, María Consuelo Cañizo, MD, PhD1,4,7* and María Díez-Campelo, MD, PhD1,7,11*

1Hematology, Salamanca Universitary Hospital, Salamanca, Spain
2Servicio de Hematología, Centro de Investigación del Cáncer, IBSAL (Instituto de Biomedicina de Salamanca) y BMCC, Universidad de Salamanca, Salamanca, Salamanca, Spain
3Statistics Department, University of Salamanca, Salamanca, Spain
4Servicio de Hematología, Centro de Investigación del Cáncer, IBSAL (Instituto de Biomedicina de Salamanca) y BMCC, Universidad de Salamanca, Salamanca, Spain
5Hematology Service, Hospital Universitario Morales Meseguer, Murcia, Spain
6Hematology Department, Hospital Universitari i Politecnic La Fe, Valencia, Spain
7GESMD, Valencia, Spain
8Servicio de Hematologia, Hospital Universitario La Fe, Valencia, Spain
9Department of Hematology, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS / CSIC), Seville, Spain
10Hospital Universitario Vall d'Hebron, Spanish MDS Cooperative Group, Barcelona, Spain
11Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain

Johann-Christoph Jann1*, Daniel Nowak, MD1*, Florian Nolte1*, Stephanie Fey1*, Verena Nowak1*, Julia Oblaender1*, Jovita Pressler1*, Alice Charlotte Fabarius, PhD1*, Uwe Platzbecker, MD2, Aristoteles Giagounidis, MD3, Katharina Goetze, MD4*, Anne Letsch5*, Detlef Haase, MD6*, Richard F. Schlenk, MD7, Gesine Bug, MD8*, Michael Luebbert, MD9*, Arnold Ganser, M.D.10, Ulrich Germing, MD11*, Claudia Haferlach, MD12, Wolf-Karsten Hofmann, MD1 and Maximilian Mossner1*

1Department of Hematology and Oncology, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany
2Carl Gustav Carus an der Technischen Universität, Universitätsklinikum, Dresden, Germany
3Medical Clinic II, St. Johannes Hospital, Duisburg, Germany
4Technische Universität München, München, Germany
5Department of Hematology and Oncology, Charite, Berlin, Germany
6Department of Hematology and Medical Oncology, Georg-August-University Göttingen, Göttingen, Germany
7University Hospital of Ulm, Ulm, Germany
8Department of Medicine, Hematology/Oncology, University of Frankfurt, Frankfurt, Germany
9Department of Hematology, Oncology and Stem Cell Transplantation, University of Freiburg Medical Center, Freiburg, Germany
10Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
11Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany
12MLL Munich Leukemia Laboratory, Munich, Germany

Lionel Ades, MD, PhD1, Christian Récher, MD PhD2, Julie Lejeune3*, Aspasia Stamatoullas, MD4*, Marie Sebert, MD5*, Jacques Delaunay, MD6*, Benedicte Samey7*, Krimo Bouabdallah, MD8*, Thorsten Braun, MD, PhD9*, Norbert Vey10, Sophie Park, MD, PhD11, Benoit de Renzis12*, Sylvie Chevret13* and Pierre Fenaux, MD, PhD14

1Service d’Hématologie Séniors, St Louis hospital, University Paris 7, Paris, France
2Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
3Hôpital Saint Louis, Assistance Publique - Hôpitaux de Paris, Paris, France
4Clinical Hematology, CENTRE HENRI BECQUEREL, Rouen, France
5Hopital Saint Louis, Paris, France
6Department of Hematology, Nantes University Hospital, Nantes, France
7Groupe Francophone des myélodysplasies, Paris, France
8CHU de Bordeaux, Bordeaux, France
9Hematologie Clinique, CHU Avicenne, Bobigny, France
10Hematology, Institut Paoli-Calmettes, Marseille, France
11CHU de Grenoble, Clinique Universitaire d’Hématologie, Université Joseph Fourier, Grenoble Cedex 9, France
12CHU, Clermont-Ferrand, France
13Biostatistics department, Hôpital Saint-Louis, Paris, France
14Service d'Hématologie Séniors, Hôpital Saint-Louis, Université Paris 7, Paris, France

Matthieu Duchmann1*, Thorsten Braun, MD, PhD2*, Uwe Platzbecker, MD, PhD3, Lionel Adès, MD, PhD4*, Marie Sébert, MD5*, François Dreyfus, MD6*, Sophie Park, MD, PhD7, Norbert Vey8, Odile Beyne Rauzy, MD, PhD9*, Stéphane De Botton, MD, PhD10*, Jean-Baptiste Micol, MD11*, Céline Berthon, MD, PhD12*, Romain Guieze, MD13*, Jean-Noel M. Bastie, MD, PhD14, Éric Solary, MD, PhD15*, Pierre Fenaux, MD, PhD16 and Raphaël Itzykson, MD, PhD17

1Université Paris 7 Diderot, Paris, France
2Clinical Hematology, CHU Avicenne, Bobigny, France
3Medizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Dresden, Germany
4Hospital St Louis, Paris 7 University, Paris, France
5Hospital St Louis, University Paris 7, Paris, France
6Cochin hospital, University Paris 5, Paris, France
7Cochin Hospital, University Paris 5, Paris, France
8Hematology, Institut Paoli-Calmettes, Marseille, France
9IUCT Oncopole, Toulouse, France
10Clinical Hematology, Gustave Roussy, Villejuif, France
11Gustave Roussy Cancer Center, Villejuif, France
12Hospital Huriez, CHRU de Lille, Lille, France
13Clinical Hematology, CHU Clermont-Ferrand, Clermont Ferrand, France
14CHU Dijon Bocage, Dijon, France
15Gustave Roussy, Villejuif, France
16University Paris 7 Diderot, Hôpital Saint-Louis, Paris, France
17Hematology Department, Saint-Louis Hospital, University Paris 7, Paris, France

Leonor Arenillas, MD1*, Xavier Calvo, MD1*, Mar Tormo, MD, PhD2, David Valcárcel, MD, PhD3, Elisa Luño, MD, PhD4*, Esther Alonso, MD5*, María Consuelo Cañizo, MD, PhD6*, Fernando Ramos, MD, PhD, MPH7*, Carmen Pedro, MD, PhD8*, Beatriz Arrizabalaga, MD9*, Alicia Bailén, MD10*, José María Raya, MD11*, María Teresa Ardanaz, MD12*, Guillermo Sanz, MD, PhD13 and Lourdes Florensa, MD, PhD1*

1Hematological Cytology Laboratory, Hospital del Mar, GRENTHE, IMIM (Hospital del Mar Research Institute), Barcelona, Spain
2Hospital Clínico Universitario de Valencia, Valencia, Spain
3Hospital Vall d'Hebrón, Barcelona, Spain
4Hematology, Hospital Universitario Central Asturias, Oviedo, Spain
5Hematology, Department of Pathology. Hospital de Bellvitge., Barcelona., Spain
6Hematology, Salamanca Universitary Hospital, Salamanca, Spain
7Hospital Universitario de León, León, Spain
8Hospital del Mar, Barcelona, Spain
9Hospital Universitario Cruces, Spanish MDS Cooperative Group, Bilbao, Spain
10Hospital Universitario Carlos Haya, Málaga, Spain
11Hospital Universitario de Canarias, Tenerife, Spain
12Hospital de Txagorritxu, Vitoria, Spain
13Hospital Universitario La Fe, Spanish MDS Cooperative Group, Valencia, Spain

Alena Moudra1*, Sona Hubackova, PhD1*, Jiri Bartek, MD, PhD1,2*, Zdenek Hodny, MD, PhD1* and Anna Jonasova, MD, PhD3*

1Department of Genome Integrity, Institute of Molecular Genetics, Academy of Sciences of the Czech republic, Prague, Czech Republic
2Centre for Genotoxic Stress Research, Institute of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark
3Haematology, Charles University and General Hospital in Prague, Prague, Czech Republic

María Díez Campelo, MD, PhD1*, Julio Davila, MD1*, Sanchez Barba Mercedes, MD2*, Maria Lopez-Pavia, MD3*, Esperanza Such, PhD1*, Teresa Bernal, MD1*, Elisa Luño1*, Fernando Ramos1*, Marisa Calabuig, MD1*, Helena Pomares, MD1*, Bernardo Gonzalez1*, Brayan Merchan, MD1*, Edgardo Barranco, MD1*, Reyes Sancho Tello1*, Marta Callejas1*, Maria Jose Requena1*, María José Jiménez1*, Maria Pedreño1*, Angeles Medina, MD1*, Ana I Vicente, PhD1*, Andrea Campeny1*, Montse Cortes Sansa1*, Carmen Pedro, MD4*, Jose Falantes, M.D.1*, Maria Jesus Arilla1*, Abelardo Bárez, MD1*, Regina Garcia, MD1*, Maria Jose Arcos1*, Valle Gomez1*, Carolina Muñoz1*, Carlos Cervero, MD1*, Javier Casaño1*, Raquel De Paz1*, Luz Amigo1*, Andres Insunza1*, Juan Antonio Muñoz1*, Maria Teresa Cedena1*, Marta Gomez1*, Patricia Font1*, Raquel Del Campo1*, Carlos Fernandez Lago1*, Jose Antonio Gonzalez Hurtado1*, Maria Dolores Linares Latorre1*, Asuncion Mora Casado1*, Maria Vahi, MD, PhD1*, Luis Benlloch3*, Guillermo Sanz, MD, PhD1 and María Consuelo Cañizo, MD, PhD1*

1GESMD, Valencia, Spain
2Departamento de Estadística, Universidad de Salamanca, Salamanca, Spain
3Hospital Universitario La Fe, GESMD, Valencia, Spain
4Hospital del Mar, GESMD, Valencia, Spain

Hanadi Ramadan, BA1*, Vu H. Duong, MD2, Najla H. Al Ali, BDS, MSc1*, Eric Padron, MD1, Ling Zhang, MD3, Jeffrey E Lancet, MD1, Alan F. List, MD1 and Rami S. Komrokji, MD1

1Malignant Hematology Department, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL
2Department of Medicine, University of Maryland School of Medicine, Baltimore, MD
3Department of Hematopathology and Laboratory Medicine, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL

Joanna (Asia) Grabska, MD1, Bijal D. Shah, MD2, Najla H. Al Ali, BDS, MSc1*, Eric Padron, M.D.3, Hanadi Ramadan, BA1*, Jeffrey E Lancet, MD1, Alan F. List, MD4 and Rami S. Komrokji, MD5

1Malignant Hematology Department, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL
2Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
3H Lee Moffitt Cancer Center & Research Institute, Tampa, FL
4Department of Hematologic Malignancies, Moffitt Cancer Center and Research Institute, Tampa, FL
5H. Lee Moffitt Cancer Center, Tampa, FL

Thierry Guillaume, MD, PhD1*, Virginie Dehame, MSc2*, Patrice Chevallier, MD, PhD1*, Pierre Peterlin, MD1*, Marc Grégoire, PhD2*, Philippe Moreau3*, Daniel B Rubinstein, MD4, Eddy Pichinuk, PhD5* and Daniel H Wreschner, MD5*

1Department of Hematology, Nantes University Hospital, Nantes, France
2INSERM U892, Cancer Research Center Nantes-Angers, Nantes, France
3University of Nantes, Nantes, France
4Biomodifying, LLC, Silver Spring
5Departments of Cell Research and Immunology, Tel Aviv University, Ramat Aviv, Israel

Thomas Prebet, MD1,2, Jacques Delaunay, MD3*, Eric Wattel, MD PhD4, Thorsten Braun, MD, PhD5*, Pascale Cony-Makhoul, M.D.6*, Sophie Dimicoli, MD7*, Stefan Wickenhauser, MD8*, Julie Lejeune9*, Sylvie Chevret10*, Fatiha Chermat11*, Pierre Fenaux, MD, PhD12,13,14 and Norbert Vey15

1Dept of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT
2Groupe Francophone des Myelodysplasies, Paris, France
3Department of Hematology, Nantes University Hospital, Nantes, France
4Lyon I University, Lyon, France
5Hematologie Clinique, CHU Avicenne, Bobigny, France
6Hematology department, Centre Hospitalier Annecy-Genevois, Site Annecy, Metz-Tessy, France
7service d'hematologie, CHU Bordeaux, Pessac, France
8CH Nimes, Nimes, France
9Hôpital Saint Louis, Assistance Publique - Hôpitaux de Paris, Paris, France
10Statistics St-Louis Hospital, Paris 7, Paris, France
11GFM, Hôpital Saint Louis, Paris, France
12Service d'Hématologie Séniors, Hôpital Saint-Louis, Université Paris 7, Paris, France
13Service d'Hématologie Clinique, Hopital Avicenne Université Paris XIII, Bobigny, France
14Groupe Francais des myélodysplasies (GFM), Paris, France
15Hematology, Institut Paoli-Calmettes, Marseille, France

Amer M. Zeidan, MBBS, MHS1, B. Douglas Smith2, Hetty E. Carraway, MD, MBA3, Ivana Gojo, MD2, Sarah Sakoian4*, Steven D. Gore, MD5 and Amy E. DeZern, MD, MHS6

1Yale University School of Medicine, New Haven, CT
2Johns Hopkins University, Baltimore, MD
3Leukemia Program, Cleveland Clinic, Cleveland, OH
4Johns Hopkins University School of Medicine, Baltimore, MD
5Yale Cancer Center, New Haven, CT
6Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD

Helena Pomares, MD1*, Isabel Sánchez-Ortega, MD, PhD1*, Esther Alonso, MD2*, Javier Grau, MD3*, Rafael F. Duarte, MD, PhD4, Anna Sureda, MD, PhD1* and Montserrat Arnan, MD, PhD1*

1Institut Català d'Oncologia, Hospital Duran i Reynals, Barcelona, Spain
2Hematology, Department of Pathology. Hospital de Bellvitge., Barcelona., Spain
3Hematology Service, Institut Català d'Oncologia. Hospital Germans Trias i Pujol, Institut de Recerca Contra la Leucèmia Josep Carreras, Universitat Autònoma de Barcelona, Badalona, Spain
4Department of Hematology. Hospital Puerta de Hierro, Madrid, Spain

Roman Shapiro, MD1, Alla Iansavichene, BSc, MLIS1* and Alejandro Lazo-Langner, MD, MSc2

1London Health Science Center, London, ON, Canada
2Division of Hematology, London Health Sciences Centre, London, ON, Canada

Ellen K. Ritchie, MD1, Apurv Agrawal, MD2*, Kashyap B Patel, MD3*, Seth Rosen, MD4*, Amy Law, MD, BA5*, Jeffrey M Skolnik, MD6* and Ashkan Lashkari, MD,7

1Division of Hematology / Oncology, Weill Cornell Medical College, New York, NY
2New Jersey Hematology Oncology Associates, Brick, NJ
3Carolina Blood and Cancer Care, Rock Hill, SC
4Hem-Onc Associates of Treasure Coast, Port Lucie, FL
5Desert Hematology Oncology Medical Group, Inc., Rancho Mirage, CA
6TetraLogic Pharmaceuticals, Malvern, PA
7Wellness Oncology, Omid S. Shaye Medical Corp., West Hills, CA

Marta Cabezon1*, Joan Bargay, MD, PhD2*, Blanca Xicoy, MD, PhD1*, Laura Palomo, MSc3*, Sílvia Marcé, PhD1*, Ramón Guàrdia, MD, PhD4*, Salut Brunet, MD, PhD5*, Carmen Pedro, MD, PhD6*, Mar Tormo, MD, PhD7, Vera Ademà, MSc3*, Victor Marco8*, Lourdes Escoda, MD, PhD9*, Llorenç Font, MD, PhD10*, Elena Rámila, MD, PhD11*, Josep Maria Martí, MD, PhD12*, David Valcarcel, MD, PhD13, Josep Borras2*, Evarist Feliu, MD, PhD1*, Fuensanta Millá, MD, PhD1* and Lurdes Zamora, PhD1*

1Hematology Service, ICO-Hospital Germans Trias i Pujol, Institut de Recerca Contra la Leucèmia Josep Carreras, Universitat Autònoma de Barcelona, Badalona, Spain
2Hospital Son Llàtzer, Palma de Mallorca, Spain
3MDS Research Group, Institut de Recerca Contra la Leucèmia Josep Carreras, ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain
4ICO Girona- Hospital Josep Trueta, Girona, Spain
5Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
6Hospital del Mar, Barcelona, Spain
7Hospital Clínico Universitario de Valencia, Valencia, Spain
8Hospital Arnau de Vilanova, Spanish MDS Cooperative Group, Lleida, Spain
9ICO-Hospital Joan XXIII, Tarragona, Spain
10Hospital Verge de la Cinta, Tortosa, Spain
11Hospital Parc Taulí, Sabadell, Spain
12Hospital Mútua de Terrassa, Terrassa, Spain
13Department of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain

*signifies non-member of ASH